1. Twenty-nine human urogenital tumors were transplanted into athymic nude mice with the genetic background of BALB/c which were kept under the specific pathogen free condition. The results were as follows (Table 1):
1) The tumor take was confirmed in 12 of the neoplasms, which consisted of 2 (66%) of
3 renal cell carcinomas, 1 (50%) of 2 ureteral carcinomas, 8 (80%) of carcinomas of the urinary bladder and 1 (11%) of 9 testicular tumors.
2) Of these neoplasms, 7 serially transplantable tumors were established, including 2 (100%) of the renal cell carcinomas and 5 (62.5%) of the carcinomas of the urinary bladder.
3) At present, the longest maintenance is in the 6th passage and the shortest in the 2nd passage, both being of the carcinomas of the urinary bladder.
4) No metastatic lesions were revealed in any of the nude mice transplanted with tumors.
2. Of the 7 maintained tumors, 2 renal cell carcinomas and 2 carcinomas of the urinary bladder were examined in detail by light microscopy, and it was proved that the 1st and 2nd passage retained the original morphological characteristics well (Fig. 2-10).
3. A human prostatic carcinoma which was in the 14 passage in nude mice at the examination was treated as described below.
1)
60Co irradiation was performed once over the whole body. Since all nude mice, both of 1000 rad and 2000 rad groups, died early, the statistical evaluation could not be made on their growth curves (Fig. 11). Histological damages to the tumor used were revealed in light and electron microscopic findings, so that irradiation appeared to become more effective if performed by an improved method (Fig. 19-21, 31).
2) Administration of adriamycin in the intraperitoneal doses of 1, 2 and 4mg/kg was shown to be ineffective against the tumor used either by the growth curve or by light microscopic examination (Fig. 12, 22). Electron microscopy, however, proved the drug to have been more or less effective in treating the tumor (Fig. 32).
3) Administration of estramustine phosphate did not elicit retardation in tumor growth (Fig. 13). By electron microscopy, however, the activity of this drug on tumor tissue was more distinct than by microscopy (Fig. 23, 33).
4) Platinum complex preparation were administered twice (day 1 and 5 after transplatation) to nude mice intraperitoneally. In CPDD (cis platinum (II) dichlorodiamine) 5mg/kg and FOCD (platinum oxalate cis dach) 20mg/kg groups, significant inhibitory effects on tumor growth were revealed in terms of growth curves and by histological examination by light and electron microscopies (Fig. 14, 15, 25-29, 35).
View full abstract